Clinical Trial

The Effect of Cold Vapor on Dyspnea, Thirst, Nausea, and Physiological Parameters in the PACU After Laparoscopic Inguinal Hernia Surgery

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 16, 2026 (before its estimated August 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Cold vapor application is considered a promising intervention with the potential to alleviate side effects associated with anesthesia and surgery in the postoperative period. This study aims to determine the effect of cold vapor inhalation on dyspnea, thirst, nausea, and physiological parameters following laparoscopic inguinal hernia surgery. Hypotheses (H1); H1a: Patients administered cold vapor will report lower dyspnea severity compared to the control group. H1b: Patients administered cold vapor will report lower thirst levels compared to the control group. H1c: Patients administered cold vapor will report lower nausea severity compared to the control group. H1d: Patients administered cold vapor will show significant differences in physiological parameters compared to the control group.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-27.
Trial Details
NCT Number NCT07273162
Lead Sponsor TC Erciyes University
Conditions Patients Undergoing Laparoscopic Inguinal Hernia Repair
Enrollment 66 participants
Start Date 2025-12-20
Primary Completion 2026-08-01 (estimated)
Study Completion 2026-09-01 (estimated)
Updated on ClinicalTrials.gov 2026-01-16